1-3 of 3
Naheed Mir
Close
Sort by
Journal Articles

A Large London District General Hospital Highlights CLL and Bame As Risk Factors for Severe Disease Amongst Haematology-Oncology Patients

Isabel Farmer, Samah Babiker, Jumoke Stella Okikiolu, Matthew Steel, Chandima Wanniarachchi, Shona Littlewood, Yishi Tan, Kameta Imaeva, Ana Duran, MD, Evdoxia Douvali, Murugaiyan Thanigaikumar, Sunil Gupta, Tullie Yeghen, Sabia Rashid, Naheed Mir, Satyajit Sahu, Sarah Oram
Journal: Blood
Blood (2020) 136 (Supplement 1): 5.
https://doi.org/10.1182/blood-2020-134341
Published: 2020
Journal Articles

R-GCVP As Second Line Treatment in Elderly Patients with DLBCL Who Fail R-CHOP and Are Not Candidates for Intensive Therapy

Betty Gration, MBBS, Ana Duran, MD, Naheed Mir, BSc, FRCP, FRCPath, Lisa Yuen, MPharm, PgDip, IP, Marcus Warner, MPharm, PG Dip GPP, Karen Stanley, RGN, MSc Advanced Practice, Jessica Brady, MBBCh, FRCR, George Mikhaeel, MB BCh, MSc, FRCR, Paul A Fields, MD PhD, David Wrench, MA, MBBChir, FRCPath, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4133.
https://doi.org/10.1182/blood.V130.Suppl_1.4133.4133
Published: 2017
Journal Articles

Addition of Anti-Viral Therapy to Chemotherapy Improves Overall Survival In Acute and Lymphomatous Adult T-Cell Leukaemia/Lymphoma (ATLL)

Andrew Hodson, MD, Silvia Montoto, MD, Naheed Mir, MD, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Kate Cwynarski, MD, PhD, Kirit M Ardeshna, MD, Thurai Kumaran, MD, Estella Matutes, MD, PhD, Graham Talyor, MD, Paul Fields, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3961.
https://doi.org/10.1182/blood.V116.21.3961.3961
Published: 2010